Acute Oxalate Nephropathy Associated With Orlistat, a Gastrointestinal Lipase Inhibitor
- 31 January 2007
- journal article
- case report
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 49 (1), 153-157
- https://doi.org/10.1053/j.ajkd.2006.10.004
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Acute oxalate nephropathy due to ethylene glycol ingestionKidney International, 2006
- Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretionKidney International, 2004
- Rapidly progressive irreversible renal failure in patients with pancreatic insufficiencyAmerican Journal of Kidney Diseases, 2003
- Acute Oxalate Nephropathy After Ingestion of Star FruitAmerican Journal of Kidney Diseases, 2001
- Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for ObesityObesity Research, 2000
- Crystal-induced acute renal failureAmerican Journal Of Medicine, 1999
- Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With OrlistatJama-Journal Of The American Medical Association, 1999
- Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind studyDiabetes Care, 1998
- Iatrogenic acute oxalate nephropathyNephrology Dialysis Transplantation, 1995
- Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.The Journal of Antibiotics, 1987